BiotechTube

AVI-7288

Phase 1Completed
0 watching 0 views this week💤 Quiet
30
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Marburg Hemorrhagic Fever

Conditions

Marburg Hemorrhagic Fever

Trial Timeline

May 1, 2013 → Jan 1, 2014

NCT ID
NCT01566877

About AVI-7288

AVI-7288 is a phase 1 stage product being developed by United Therapeutics for Marburg Hemorrhagic Fever. The current trial status is completed. This product is registered under clinical trial identifier NCT01566877. Target conditions include Marburg Hemorrhagic Fever.

Hype Score Breakdown

Clinical
10
Activity
5
Company
7
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT01566877Phase 1Completed

Competing Products

2 competing products in Marburg Hemorrhagic Fever

See all competitors
ProductCompanyStageHype Score
AVI-6003 + PlaceboUnited TherapeuticsPhase 1
30
galidesivir + placeboBioCryst PharmaceuticalsPhase 1
28

Other Products from United Therapeutics

TreprostinilApproved
82
RemodulinApproved
82
Remodulin (treprostinil sodium)Approved
82
Intravenous TreprostinilApproved
82
Intravenous/Subcutaneous Treprostinil; Oral TreprostinilApproved
82